medigraphic.com
ISSN 1817-5996 (Electronic)

2022, Number 4

<< Back Next >>

Rev Cub de Reu 2022; 24 (4)

From limb weakness to a systemic involvement: Poems syndrome case two report and review of the literature

Rodríguez SE, Sarmiento PDA, Bernal BA, Cano MLA, Usma VAF, Saldarriaga RLM

Language: Spanish
References: 10
Page:
PDF size: 227.21 Kb.


ABSTRACT

POEMS syndrome is a rare and infrequent paraneoplastic syndrome, which occurs mainly in the sixth decade of life, characterized by multisystem involvement with a predominance of demyelinating neuropathy, which encompasses diverse and heterogeneous clinical manifestations and whose diagnosis requires a high index of suspicion. We present two cases of patients who consulted due to unusual symptoms and whose loss of strength led to an approach due to multisystem involvement that concluded with the diagnosis of this disease.


REFERENCES

  1. Dispenzieri A. POEMS syndrome: 2021 Update on diagnosis, risk-stratification, and management. Am J Hematol. 2021;96(7):872-88. DOI: https://doi.org/10.1002/ajh.262401.

  2. Talbot A, Jaccard A, Arnulf B. Syndrome POEMS: diagnostic, prise en charge et traitements. Rev Med Interne (French). 2021;42(5):320-9. DOI: https://doi.org/10.1016/j.revmed.2021.02.0072.

  3. Jurczyszyn A, Castillo JJ, Olszewska-Szopa M, Kumar L, Thibaud S, Richter J, et al. POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis. Clin Lymphoma Myeloma Leuk. 2021;S2152-2650(21):02388-90. DOI: https://doi.org/10.1016/j.clml.2021.10.0073.

  4. Humeniuk MS, Gertz MA, Lacy MQ, Kyle RA, Witzig TE, Kumar SK, et al. Outcomes of patients with POEMS syndrome treated initially with radiation. Blood. 2013;122(1):68-73. DOI: https://doi.org/10.1182/blood-2013-03-4870254.

  5. Faizan U, Sana MK, Farooqi MS, Hashmi H. Efficacy and Safety of Regimens Used for the Treatment of POEMS Syndrome- A Systematic Review. Clin Lymphoma Myeloma Leuk. 2022;22(1):e26-e33. DOI: https://doi.org/10.1016/j.clml.2021.07.0335.

  6. Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, et al. POEMS syndrome: definitions and long-term outcome. Blood. 2003;101(7):2496-506. DOI: https://doi.org/10.1182/blood-2002-07-22996.

  7. Allam JS, Kennedy CC, Aksamit TR, Dispenzieri A. Pulmonary manifestations in patients with POEMS syndrome: a retrospective review of 137 patients. Chest. 2008;133(4):969-74. DOI: https://doi.org/10.1378/chest.07-18007.

  8. Nasu S, Misawa S, Sekiguchi Y, Shibuya K, Kanai K, Fujimaki Y, et al. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry. 2012;83(5):476-9. DOI: https://doi.org/10.1136/jnnp-2011-3017068.

  9. Koike H, Iijima M, Mori K, Yamamoto M, Hattori N, Watanabe H, et al. Neuropathic pain correlates with myelinated fibre loss and cytokine profile in POEMS syndrome. J Neurol Neurosurg Psychiatry. 2008;79(10):1171-9. DOI: https://doi.org/10.1136/jnnp.2007.1356819.

  10. Keddie S, Lunn MP. POEMS syndrome. Curr Opin Neurol. 2018;31(5):551-8. DOI: https://doi.org/10.1097/WCO.000000000000061010.




2020     |     www.medigraphic.com